DrugPatentWatch Report Store
Showing 337–348 of 905 results
- Drug Patent Reports
IMCIVREE (setmelanotide acetate) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
INBRIJA (levodopa) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
INCRUSE ELLIPTA (umeclidinium bromide) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
INDIGOTINDISULFONATE SODIUM Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
INGREZZA (valbenazine tosylate) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
INJECTAFER (ferric carboxymaltose) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
INLYTA (axitinib) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
INOMAX (nitric oxide) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
INPEFA (sotagliflozin) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
INQOVI (cedazuridine; decitabine) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
INREBIC (fedratinib hydrochloride) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
INTRAROSA (prasterone) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now
